According to the recent report by IMARC Group, titled “Cannula Market Report by Product (Cardiac Cannulas, Nasal Cannulas, Vascular Cannulas, Dermatology Cannulas, Arthroscopy Cannulas, and Others), Type (Neonatal Cannulas, Straight Cannulas, Winged Cannula, Wing with Port Cannula, and Others), Size (14G, 16G, 18G, 20G, 22G, 24G, 26G), Material (Plastic (PVC) Cannulas, Silicone Cannulas, Metal Cannulas (Stainless Steel)), Application (Cardiovascular Surgery, Oxygen Therapy, General Surgery, Cosmetic/Plastic Surgery, Orthopedic Surgery, and Others), End-User (Hospitals, Ambulatory Surgery Centers (ASCs), and Others), and Region 2025-2033,” the global cannula market reached a value of USD 168.4 Million in 2024. A cannula can be defined as a hollow, flexible tube with a sharp, retractable inner core that can be inserted into a vein, body cavity or artery. It is used to remove fluids or gather samples from the body or deliver fluids to the body. There are different kinds of cannulas available for a range of procedures in different sizes. Cannulas are now also being used over hypodermic needles for injecting fillers due to their associated benefits like greater flexibility, less risk of bruising or bleeding, and reduced pain. As a result, they find applications in blood banks, hospitals, pathology labs, and ambulatory surgery centers (ASCs).
Global Cannula Market Trends:
One of the major factors impelling the market growth is the continuing spread of the coronavirus disease (COVID-19). The pandemic has led to a spike in the hospitalization of the affected patients, which, in turn, has stimulated the demand for cannulas. Apart from this, the rising cases of cardiovascular diseases over the past decade and the increasing inclination toward minimally invasive surgeries (MIS) are also contributing to the market growth. Furthermore, several manufacturers are introducing advanced cannulas, which is creating a positive outlook for the market. For instance, Uni-flo2 Single Nasal Cannula by UPODS, LLC and 3B Medical’s Freedom X oxygen cannula are designed to offer maximum comfort to the patients while receiving oxygen. Similarly, Medtronic has launched Kyphon Cannula in 2020 for balloon kyphoplasty surgeries in the United States. Some of the other factors bolstering the market growth are the rising popularity of cosmetic surgeries, increasing advancements in medical sciences, and favorable government policies for offering primary healthcare services. Looking forward, the market value is projected to reach USD 278.8 Million by 2033, expanding at a CAGR of 5.47% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Product, Application, Type, Size, Material, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith & Nephew PLC, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated and Terumo Corporation |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800